KLOW combines four peptides with complementary mechanisms of action: TB-500 (Thymosin Beta-4): Promotes angiogenesis, cell migration, and tissue repair by regulating actin, a key protein in cell structure[1]. Preclinical studies demonstrate accelerated wound healing, reduced inflammation, and tissue regeneration[2]. BPC-157: A gastric pentadecapeptide that supports tendon, ligament, and muscle healing through enhanced angiogenesis and growth factor modulation[3]. Animal studies show favorable tissue repair outcomes[4]. KPV: A C-terminal tripeptide fragment of α-MSH with potent anti-inflammatory properties. It inhibits NF-κB signaling and reduces pro-inflammatory cytokines without melanotropic effects[5][6]. GHK-Cu: A naturally occurring copper peptide that stimulates collagen and elastin synthesis, promotes wound healing, and modulates gene expression related to tissue remodeling[7][8].
